[Oligopeptide therapies targeting the molecules of brain tumors].
Ueba
Tetsuya
T
Department of Neurosurgery, Kishiwada City Hospital.
D000236:Adenoma / Q000188:drug therapy; D000595:Amino Acid Sequence; D000818:Animals; D001667:Binding, Competitive; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000209:etiology; D015195:Drug Design; D016222:Fibroblast Growth Factor 2 / Q000737:chemistry / Q000378:metabolism; D005910:Glioma / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D015282:Octreotide / Q000627:therapeutic use; D009842:Oligopeptides / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000188:drug therapy; D051497:Receptor, Fibroblast Growth Factor, Type 2 / Q000737:chemistry / Q000378:metabolism; D015398:Signal Transduction
D009842:Oligopeptides; D016222:Fibroblast Growth Factor 2; D051497:Receptor, Fibroblast Growth Factor, Type 2; D015282:Octreotide